DRIO

+ Watchlist + Portfolio

DarioHealth Corp.

Recurring revenue Regulated industry Consumer brandTags from an AI model reading the company description.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $6.30
52-Week Range: $5.85 – $16.55
Market Cap: $63.30M
P/E (TTM): —
EPS (TTM): -2.28
Dividend Yield: 0.00%

Advanced Metrics

Price/Book: 0.86
PEG Ratio: —
Return on Equity: -59.91%
Return on Assets: -19.42%
Gross Margin: 61.57%
Operating Margin: -125.15%
Profit Margin: -169.87%
Current Ratio: 2.31
Debt/Equity: 0.59
Total Debt: $32.41M
Free Cash Flow: $-12.35M
Revenue Growth: -3.60%
Earnings Growth: —
Enterprise Value: $81.76M

DRIO Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$27.66M	$20.35M	$27.04M	$22.36M
Cost of Revenue	$18.00M	$14.37M	$13.77M	$9.69M
Gross Profit	$9.65M	$5.98M	$13.27M	$12.66M
Research & Development	$19.65M	$20.25M	$24.18M	$13.79M
Selling, General & Admin	$46.82M	$41.92M	$46.83M	$35.53M
Operating Expenses	$66.47M	$62.17M	$71.01M	$49.32M
Operating Income	-$56.81M	-$56.19M	-$57.74M	-$36.66M
EBITDA	-$55.60M	-$51.20M	-$37.17M	-$35.45M
Pretax Income	-$62.19M	-$59.36M	-$44.60M	-$41.61M
Income Tax	$4.00K	$64.00K	-$1.85M	$105.00K
Net Income	-$62.19M	-$59.43M	-$42.75M	-$41.71M
Diluted EPS	-50.80	-38.60	-12.27	-10.12
Diluted Shares	1.18M	1.42M	2.45M	3.98M

DRIO Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$49.36M	$36.80M	$27.76M	$21.80M
Receivables	$7.14M	$3.64M	$5.35M	$2.93M
Inventory	$7.96M	$5.06M	$4.75M	$4.32M
Current Assets	$65.52M	$47.33M	$40.53M	$35.07M
Total Assets	$119.19M	$96.39M	$118.88M	$110.08M
Current Liabilities	$19.35M	$12.49M	$16.64M	$9.32M
Long-Term Debt	$18.11M	$24.59M	$23.47M	$30.75M
Total Debt	$28.05M	$29.54M	$30.19M	$31.75M
Total Liabilities	$39.19M	$38.24M	$46.87M	$42.15M
Retained Earnings	-$285.85M	-$349.36M	-$390.34M	-$452.08M
Shareholders' Equity	$80.00M	$58.14M	$72.02M	$67.92M
Working Capital	$46.17M	$34.84M	$23.89M	$25.74M
Net Debt	—	—	$1.16M	$8.94M

DRIO Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	-$47.84M	-$30.38M	-$38.56M	-$25.94M
Capital Expenditure	-$573.00K	-$584.00K	-$138.00K	-$142.00K
Free Cash Flow	-$48.42M	-$30.96M	-$38.70M	-$26.08M
Depreciation & Amortisation	$4.72M	$4.99M	$7.43M	$3.14M
Stock-Based Compensation	$16.98M	$19.70M	$15.80M	$9.37M
Investing Cash Flow	-$573.00K	-$547.00K	-$8.93M	-$4.34M
Financing Cash Flow	$61.94M	$18.25M	$38.53M	$24.31M
Share Repurchases	-$134.00K	$0.00	—	—
Net Change in Cash	$13.52M	-$12.67M	-$8.96M	-$5.97M

DRIO Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Revenue	$6.75M	$5.37M	$5.01M	$5.23M	$5.58M	$5.18M
Cost of Revenue	$2.87M	$2.40M	$1.99M	$2.43M	$2.38M	$1.99M
Gross Profit	$3.88M	$2.96M	$3.02M	$2.80M	$3.20M	$3.19M
Research & Development	$4.11M	$3.72M	$3.33M	$2.63M	$2.38M	$2.10M
Selling, General & Admin	$9.18M	$8.44M	$9.17M	$8.73M	$8.12M	$7.57M
Operating Expenses	$13.29M	$12.16M	$12.50M	$11.37M	$10.51M	$9.67M
Operating Income	-$9.41M	-$9.20M	-$9.48M	-$8.56M	-$7.31M	-$6.48M
EBITDA	-$7.95M	-$8.40M	-$8.76M	-$7.32M	-$6.52M	-$5.96M
Pretax Income	-$9.21M	-$12.99M	-$10.47M	-$8.95M	-$8.19M	-$7.60M
Income Tax	$22.00K	$0.00	$0.00	$83.00K	$57.00K	$328.00K
Net Income	-$9.23M	-$12.99M	-$10.47M	-$9.03M	-$8.25M	-$7.92M
Diluted EPS	-2.87	3.54	-2.96	—	-1.25	0.85
Diluted Shares	2.37M	2.48M	3.14M	—	6.58M	9.34M

DRIO Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Cash & Equivalents	$27.85M	$21.95M	$31.91M	$21.80M	$14.98M	$6.63M
Receivables	$5.89M	$5.39M	$5.19M	$2.93M	$4.30M	$4.15M
Inventory	$4.62M	$4.61M	$4.87M	$4.32M	$4.17M	$3.72M
Current Assets	$38.56M	$32.17M	$42.19M	$35.07M	$28.73M	$22.13M
Total Assets	$115.60M	$108.33M	$117.73M	$110.08M	$103.28M	$96.59M
Current Liabilities	$19.16M	$9.75M	$9.28M	$9.32M	$9.36M	$9.58M
Long-Term Debt	$18.90M	$30.50M	$30.62M	$30.75M	$30.93M	$31.06M
Total Debt	$30.34M	$31.62M	$31.64M	$31.75M	$31.82M	$32.41M
Total Liabilities	$41.90M	$44.34M	$42.79M	$42.15M	$40.90M	$41.50M
Retained Earnings	-$404.41M	-$422.97M	-$441.83M	-$452.08M	-$460.33M	-$468.25M
Shareholders' Equity	$73.70M	$63.99M	$74.93M	$67.92M	$62.38M	$55.09M
Working Capital	$19.41M	$22.42M	$32.91M	$25.74M	$19.38M	$12.55M
Net Debt	$1.34M	$8.54M	—	$8.94M	$15.95M	$24.43M

DRIO Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Operating Cash Flow	-$6.67M	-$6.03M	-$7.35M	-$5.89M	-$6.03M	-$6.08M
Capital Expenditure	-$31.00K	-$44.00K	-$41.00K	-$26.00K	-$31.00K	-$38.00K
Free Cash Flow	-$6.70M	-$6.08M	-$7.39M	-$5.91M	-$6.06M	-$6.12M
Depreciation & Amortisation	$1.26M	$802.00K	$546.00K	$534.00K	$524.00K	$515.00K
Stock-Based Compensation	$2.34M	$2.04M	$2.95M	$2.04M	$1.44M	$632.00K
Investing Cash Flow	-$31.00K	-$44.00K	-$41.00K	-$4.23M	-$826.00K	-$2.29M
Financing Cash Flow	$6.82M	$124.00K	$17.39M	-$19.00K	$0.00	$0.00
Net Change in Cash	$111.00K	-$5.95M	$10.00M	-$10.13M	-$6.85M	-$8.37M

Market Snapshot

About

DarioHealth Corp. is a digital health company offering a digital therapeutics platform for chronic disease management. The company's solutions focus on conditions including diabetes, hypertension, musculoskeletal disorders, and behavioral health. DarioHealth's platform combines biosensors, mobile applications, data analytics, and coaching to provide personalized health management. The company targets both direct-to-consumer users and business-to-business channels including employers, health plans, and providers. DarioHealth aims to improve health outcomes while reducing healthcare costs through its integrated digital care platform.